Aruna Roy, Patkar, Bhushan write to govt against GM mustard

Image
Press Trust of India New Delhi
Last Updated : Sep 22 2016 | 10:07 PM IST
Prominent civil society members Aruna Roy, Medha Patkar and Prashant Bhushan today urged the government not to approve the release of GM mustard citing "non-scientific, opaque and deceptive" processes adopted by country's biotech regulator in studying it.
In a letter to Union Environment Minister Anil Madhav Dave, they said, "We write to you to communicate our rejection of transgenics in our food, farming and environment and to urge you to stop your regulators from providing any regulatory clearances to GMOs and their environmental release."
"This applies to the current case of GM mustard in particular (all the 3 GMOs) but also all GM foods," said the letter written by citizens, which also include former health and agriculture ministers, eminent academics cutting across different disciplines and senior retired bureaucrats.
They referred to the report on GM mustard's biosafety datasubmitted by a sub-committee which was constituted by country's biotech regulator- Genetic Engineering Appraisal Committee (GEAC).
After the sub-committee examined the data, the report was placed on the Environment Ministry's website inviting comments from stakeholders within a period of 30 days before the biotech regulator took a decision.
"We urge you to extend the public feedback time to 120 days," they said.
The report claimed that the hybrid variety did not pose any risk to biodiversity or agro-ecosystem.
"We are alarmed at the non-scientific, opaque and deceptive processes being adopted by the regulators in the name of collecting public feedback on GM mustard," they said.
They also urged the government to ask the regulator to put out the full biosafety dossier in the public domain for independent scientific scrutiny as has been done with other GMOs in the past.
"...And make sure that feedback is collected in all forms without any prescribed formats," the letter said.
Terming the GMOs as herbicide-tolerant, the letter said the adverse impacts of such crops including greater agri- chemical usage, more chemical residues in food and environment, entrapping of farmers in a seed-and-chemicals market trap and creation of super-weeds are well documented.
They said they have been urging the regulator that this
application should not have been accepted or processed by regulators at all from the beginning.
"There are several other issues including the fact that yield increase claims are unfounded and that there are various ways and means by which India's oilseeds production can be increased without resorting to transgenic technology.
"In fact, the release of (even non-transgenic) hybrids has not resulted in any yield or production increases of mustard as evidence shows," the letter said.
They said that after a special meeting convened by GEAC to listen to citizens' representatives, it had become clearer that the regulatory body is limiting itself to only "narrow biosafety assessment" that too in an "unscientific and incomplete manner".
"There are numerous issues of concern that remain totally unresolved with this kind of regulation - what about the rights of a farmer who wishes to remain GM-Free but finds her or his crop contaminated by neighbouring GM crop?
"What about the rights of consumers who wish to know what is in their food, have a right to informed choices and have a right to safe food? Will a labelling regime ever work in a country where most consumption is not of packaged commodities, but open?" they added.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 22 2016 | 10:07 PM IST

Next Story